Epidermal growth factor receptor (EGFR) is the most common mutation driving the carcinogenesis of lung adenocarcinoma (LUAD), with a mutation rate of up to 55% in Asian LUAD patients (Zhang et al., 2021). This evidence concerns the gene EGFR and lung adenocarcinoma.